1983
DOI: 10.1007/bf02055856
|View full text |Cite
|
Sign up to set email alerts
|

Acute dimethyl sulphoxide therapy in experimental brain oedema, effect of dose and concentration on brain water and electrolyte content

Abstract: Albino rabbits with experimental brain oedema produced by a combined left hemisphere cryogenic injury and a metabolic insult by a 6-aminonicotinamide (6-ANA) were administered intravenous dimethyl sulphoxide (DMSO) in varying concentrations and doses in the following manner: Subgroup A (concentration response) received 1.0 g/kg bolus of a 10, 20, 30, or 40% solution. Subgroup B (dose response) received as a 20% solution a 1.0 g/kg bolus, 1.5 g/kg bolus, or 2.0 g/kg infusion. One hour following administration o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…Additional therapy administered to Case 1 included dimethyl sulphoxide, magnesium sulphate, thiamin, aspirin (as anticoagulant) and vitamin E for its antioxidant effects in brain mitochondria (Navarro and Boveris 2008). The use of dimethyl sulphoxide has been advocated for the treatment of cerebral oedema (Tsuruda et al 1983) and for the hydroxyl radical scavenging properties of this compound (Santos et al 2003). Administration of magnesium sulphate was aimed at elevation of seizure threshold (Hallak 1998) and neuroprotective properties of the drug in experimental models of cerebral ischaemia (Muir 1998).…”
Section: Discussionmentioning
confidence: 99%
“…Additional therapy administered to Case 1 included dimethyl sulphoxide, magnesium sulphate, thiamin, aspirin (as anticoagulant) and vitamin E for its antioxidant effects in brain mitochondria (Navarro and Boveris 2008). The use of dimethyl sulphoxide has been advocated for the treatment of cerebral oedema (Tsuruda et al 1983) and for the hydroxyl radical scavenging properties of this compound (Santos et al 2003). Administration of magnesium sulphate was aimed at elevation of seizure threshold (Hallak 1998) and neuroprotective properties of the drug in experimental models of cerebral ischaemia (Muir 1998).…”
Section: Discussionmentioning
confidence: 99%
“…Studies conducted in a number of species suggested that i.v. administration was effective in reducing intracranial pressure and volume (Camp, James, & Werner, 1981;Ikeda & Long, 1990;Kulah, Akar, & Baykut, 1990;Rucker, Lumb, & Scott, 1981;Tsuruda, James, Werner, Camp, & Rasmussen, 1983;Tung, James, Drummond, & Moore, 1986). Part of its therapeutic efficacy may be based on its ability to scavenge oxygen-free radicals, which have been implicated in induced tissue damages when given before, during, or several hours after tissue insult (Ali, 2001).…”
mentioning
confidence: 99%